<DOC>
	<DOCNO>NCT00863590</DOCNO>
	<brief_summary>This study assess safety , tolerability , pharmacokinetics single-dose odanacatib ( MK0822 ) without food .</brief_summary>
	<brief_title>A Single-Dose Study Safety , Tolerability , Pharmacokinetics Odanacatib ( MK0822 ) Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Subject good health Subject male age 18 45 year ( Part I ) female 60 year young Female subject postmenopausal Subject within 20 % ideal body weight Subject nonsmoker Subject multiple severe allergy food medication Subject history metabolic bone disease , kidney/bladder stone , treatment bisphosphonates Subject infection , include HIV Subject consume excessive amount caffeine alcohol Subject donate blood take another investigational drug last month Subject history illness may confound result study pose additional risk administer study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>